secwatch / observer
8-K filed August 9, 2021, 7:59 PM ET ticker TRVI CIK 0001563880
leadership confidence high sentiment neutral materiality 0.40

Trevi Therapeutics hires Lisa Delfini as CFO with $330K base salary and 100,000-share option grant

Trevi Therapeutics, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Lisa Delfini

Chief Financial Officer and principal financial officer
TRVI · Trevi Therapeutics, Inc.
Effective
2021-08-09
Filed
August 9, 2021, 7:59 PM ET
On August 9, 2021, Trevi Therapeutics, Inc. (the “Company”) announced the hiring of Lisa Delfini, who will serve as the Company’s Chief Financial Officer and principal financial officer upon her start date of August 9, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lisa Delfini was appointed as Chief Financial Officer and principal financial officer at Trevi Therapeutics, Inc..

Action
hired
Role
Chief Financial Officer and principal financial officer
Exact text from the filing
On August 9, 2021, Trevi Therapeutics, Inc. (the “Company”) announced the hiring of Lisa Delfini, who will serve as the Company’s Chief Financial Officer and principal financial officer upon her start date of August 9, 2021.
View on SEC.gov

Trevi Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001564590-21-042744
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.